Stock listing

NASDAQ:BLUE Bluebird bio Inc Stock

Follow Bluebird bio Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BLUE

$4.97 USD

Close on May 30, 2025 · No longer trades

Dec 13, 2024 to last close -21.6% · daily closes, Dec 13, 2024 – May 30, 2025
Lowest – highest close
$3.29 – $9.92 USDSince Dec 13, 2024 · lowest May 12, 2025 · highest Jan 6, 2025

Delisted NASDAQ:BLUE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BLUE
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Bluebird bio Inc on 6ix

Calls
9 calls with a replay · 9 with a transcript · latest Nov 14, 2024
Decks
27 decks · latest Jan 8, 2024

Events

CallWhenStatus
Bluebird bio (BLUE) Q3 2024 Earnings CallThu, Nov 14, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2024 Earnings CallWed, Aug 14, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q1 2024 Earnings CallThu, May 09, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q4 2023 Earnings CallTue, Mar 26, 2024 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q3 2023 Earnings CallTue, Nov 07, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2023 Earnings CallTue, Aug 08, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q4 2022 Earnings CallWed, Mar 29, 2023 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q1 2022 Earnings CallTue, Apr 05, 2022 · 8:00 AM ETReplay
Bluebird bio (BLUE) Q2 2021 Earnings CallMon, Aug 09, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2024Conference23 slidesJan 8, 2024
Corporate Update (December 2023)Corporate update17 slidesDec 11, 2023
Q2 2023 Earnings PresentationEarnings16 slidesAug 8, 2023
Investor Presentation (July 2023)Investor deck27 slidesJul 12, 2023
Investor Presentation (June 2023)Investor deck27 slidesJun 12, 2023
J.P. Morgan Healthcare Conference 2023Conference29 slidesJan 9, 2023
Conference Presentation (January 2021)Conference27 slidesJan 11, 2021
ASH 2019Conference38 slidesDec 10, 2019
EHA Data Review & ZYNTEGLO Approval Webcast (June 2019)Conference38 slidesJun 14, 2019
39th Annual Cowen Healthcare Conference 2019Conference10 slidesMar 12, 2019
All 27 decks
DeckKindSlidesDate
37th Annual J.P. Morgan Healthcare Conference (January 2019)Conference31 slidesJan 9, 2019
Investor Presentation (January 2019)Investor deck74 slidesJan 7, 2019
ASH 2018Conference55 slidesDec 4, 2018
EHA Analyst & Investor Webcast 2018Conference29 slidesJun 15, 2018
ASCO Analyst & Investor Webcast 2018Conference20 slidesJun 4, 2018
36th Annual J.P. Morgan Healthcare Conference (January 2018)Conference22 slidesJan 8, 2018
Investor Presentation (December 2017)Investor deck5 slidesDec 11, 2017
EHA 2017Conference40 slidesJun 23, 2017
Investor Day (June 2017)Investor day35 slidesJun 5, 2017
Investor Presentation (January 2017)Investor deck55 slidesJan 9, 2017
EORTC-NCI-AACR Molecular Targets and Cancer Therapies Symposium 2016Conference22 slidesDec 1, 2016
American Academy of Neurology Annual Meeting 2016Conference22 slidesApr 20, 2016
Investor Presentation (January 2016)Investor deck47 slidesJan 11, 2016
Investor Day (December 2015)Investor day73 slidesDec 7, 2015
EHA 2015Conference22 slidesJun 15, 2015
Investor Presentation (December 2014)Investor deck24 slidesDec 10, 2014
European Hematology Association (EHA) Congress 2014Conference26 slidesJun 16, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mary Lynne Hedley
Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Tesaro Inc (President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past); Abraxis BioScience Inc (Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past)
Director · Sep 18, 2017 – Jun 20, 2018 · Past
Denice Torres
Other companies: Seaport Therapeutics, Inc. (Board Member · Since at least Apr 30, 2026); Celldex Therapeutics, Inc. (Chief Executive Officer; The Ignited Company · Since at least Jun 5, 2025); Glaukos Corporation (Director · Since at least Mar 1, 2021); 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Surface Oncology Inc (Director · Jul 6, 2021 – Jun 8, 2022 · Past); Karuna Therapeutics Inc (Director · Dec 22, 2020 – Mar 18, 2024 · Past)
Director · Aug 10, 2020 – Nov 11, 2021 · Past
Linda Bain
Other companies: Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); Autolus Therapeutics plc (Chair of the Audit Committee, Member of the Nominating and Governance Committee · Since at least Mar 18, 2026); Arvinas, Inc. (Director · Since at least Jun 10, 2020); VBI Vaccines Inc. (Director · Jul 1, 2021 – Jan 27, 2022 · Past); Codiak BioSciences Inc (Chief Financial Officer · Oct 13, 2020 – Mar 28, 2023 · Past); Adverum Biotechnologies Inc (Chief Financial Officer · Jul 30, 2014 – Aug 21, 2015 · Past)
VP, Fin. & Business Operations · Jun 18, 2013 – Feb 26, 2014 · Past
Mitchell H Finer
Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 13, 2019 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – Jul 31, 2019 · Past)
Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past
Elisabeth Leiderman
Other companies: Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Decibel Therapeutics Inc (Chief Financial Officer · Feb 11, 2021 – Feb 25, 2022 · Past)
Director · Since at least Oct 15, 2021
Jim DeTore
Other companies: CG Oncology, Inc. (Chief Financial Officer · Since at least Nov 17, 2025); Kineta Inc. (See Remarks · Aug 4, 2016 – Aug 4, 2016 · Past)
Chief Financial Officer · Nov 10, 2014 – Dec 1, 2014 · Past
Michael Cloonan
Other companies: Sionna Therapeutics, Inc. (President & CEO, Director · Since at least Feb 6, 2025); Sage Therapeutics Inc (Chief Business Officer · Apr 2, 2018 – Feb 10, 2021 · Past)
Director · Since at least Jun 20, 2024
Nick Leschly
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Synlogic Inc (Director · Jun 10, 2021 – Jun 22, 2023 · Past)
Director · Since at least Oct 2, 2020
Jeffrey T. Walsh
Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Jul 29, 2021)
Chief Strategy Officer · Mar 11, 2019 – Aug 20, 2019 · Past
Joseph Vittiglio
Other companies: PepGen Inc. (Chief Business & Legal Officer · Since at least Dec 8, 2025)
Chief Business & Legal Officer · Since at least May 30, 2025
All 23 people
PersonSeat
Kory Wentworth
Other companies: Entrada Therapeutics, Inc. (Chief Financial Officer · Since at least Oct 28, 2021)
Principal Accounting Officer · Dec 18, 2017 – Aug 3, 2020 · Past
Marcela V Maus
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past)
Director · Sep 7, 2021 – Nov 11, 2021 · Past
O James Sterling
Other companies: Renalytix PLC (Chief Financial Officer · Jul 1, 2023 – Jul 6, 2023 · Past)
Chief Financial Officer · Since at least Jun 10, 2024
Richard Paulson
Other companies: Karyopharm Therapeutics Inc. (President and CEO, Director · Since at least Apr 4, 2025)
Director · Since at least May 30, 2025
William R Sellers
Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – Nov 11, 2021 · Past)
Director · Sep 25, 2019 – Nov 11, 2021 · Past
Andrew ObenshainPresident and CEO, Director · Since at least Nov 3, 2023
Douglas MeltonDirector · Jun 6, 2019 – Jun 18, 2020 · Past
Jessica WhittenChief Accounting Officer · Nov 4, 2021 – Feb 1, 2022 · Past
Katy BurnettPrincipal Accounting Officer · Sep 8, 2020 – Feb 16, 2021 · Past
Mark VachonDirector · Since at least Nov 6, 2024
Najoh Tita-ReidDirector · Since at least Jun 22, 2022
Richard A ColvinChief Medical Officer · Since at least May 30, 2025
Thomas J KlimaSee Remarks · Since at least May 10, 2021

Open People

Log in to ask 6ix AI your own questions about Bluebird bio Inc.